DCF — GEISINGER BLOOMSBURG HOSPITAL
Enterprise Value: $35.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$35.8M
Enterprise Value
$8.6M
PV of Cash Flows
$27.2M
PV of Terminal Value
$43.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $77.6M | $5.4M | 7.0% | $1.2M | $1.1M |
| Year 2 | $79.9M | $6.4M | 8.0% | $1.9M | $1.6M |
| Year 3 | $82.3M | $7.4M | 9.0% | $2.6M | $1.9M |
| Year 4 | $84.8M | $8.0M | 9.0% | $3.0M | $2.0M |
| Year 5 | $87.3M | $8.5M | 10.0% | $3.2M | $2.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $35.8M. Terminal value accounts for 76% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$75.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.06452598417108882
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5